findmyKOL

Rebecca Tung, MD

Basic profile

University of Central Florida

ORCID↗NPI↗
✓ Full record
RegionDavenport, FL · SoutheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL type: RegionalLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Rebecca Tung is a Dermatology physician affiliated with University of Central Florida. OpenAlex indexes 104 publications with 1,613 citations (h-index 22); ClinicalTrials.gov lists 4 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
104publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,613citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

130 Ridge Center Dr Ste 203
Davenport, FL 338376416

Telephone

863-667-6647

Provider last certified this registry record 5 Mar 2026.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    46.9%
    RNA Synthetase Inhibitor Antibacterial36.9%
    Mupirocin100%
    Part D≥727 patients
    Opioid Agonist8.3%
    Hydrocodone-Acetaminophen100%
    Part D≥178 patients

    + 2 more classes in this area

  • Anti-infectives

    41.1%
    First-generation cephalosporins25.8%
    Cephalexin100%
    Part D≥515 patients
    Tetracycline-class Drug7.9%
    Doxycycline Hyclate100%
    Part D≥161 patients

    + 5 more classes in this area

  • Dermatology

    3.7%
    Corticosteroid3.7%
    Triamcinolone Acetonide100%
    Part D≥76 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”